Suárez‐Calvet, M., Karikari, T. K., Ashton, N. J., Lantero Rodríguez, J., Milà‐Alomà, M., Gispert, J. D., . . . Molinuevo, J. L. (2020). Novel tau biomarkers phosphorylated at T181, T217 or T231 rise in the initial stages of the preclinical Alzheimer’s continuum when only subtle changes in Aβ pathology are detected. EMBO Mol Med.
Stile di citazione ChicagoSuárez‐Calvet, Marc, et al. "Novel Tau Biomarkers Phosphorylated At T181, T217 or T231 Rise in the Initial Stages of the Preclinical Alzheimer’s Continuum When Only Subtle Changes in Aβ Pathology Are Detected." EMBO Mol Med 2020.
Citazione MLASuárez‐Calvet, Marc, et al. "Novel Tau Biomarkers Phosphorylated At T181, T217 or T231 Rise in the Initial Stages of the Preclinical Alzheimer’s Continuum When Only Subtle Changes in Aβ Pathology Are Detected." EMBO Mol Med 2020.